Align Technology, Inc.
NASDAQ:ALGNMedical - Devices
-$5.99 today
- Market cap
- $11.56B
- Beta
- 1.67
- P/E (TTM)
- 28.8
- EPS (TTM)
- $6.02
Volume 0.89M
Average 1.05M
ALGN EPS (Diluted)
Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.
Align Technology, Inc.NASDAQ: ALGN
EPS (Diluted) · Q2 FY2026 · quarter ended Jun 2026
EPS (Diluted) declines year over year
Q2 FY2026 EPS (Diluted) of $1.52 fell 11.6% year over year, behind the -2.9% change in trailing-twelve-month EPS (Diluted). Sequentially, it fell 3.2% from the prior quarter. Over 3 fiscal years it compounded at +7.0% a year.
Context
- EPS (Diluted) increased in 2 of the last 3 fiscal years.
What to watch
Whether EPS (Diluted) reaches the consensus estimate from 10 analysts of $11.12 (+96.9%) for the fiscal year ending Dec 2026, a step up from the +0.5% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $1.52-3.2% QoQ
- Last fiscal yearDec 2025
- $5.65+0.5% YoY
- LTMJun 2026
- $5.76-2.9% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -11.6% | +254.8% | +266.4 pp |
| 1 year | +0.5% | +96.9% | +96.3 pp |
| 3-year CAGR | +7.0% | +33.4% | +26.4 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Diluted) history
USD · from the income statement
- Latest · FY2025
- 5.65 USD
- Year-over-year change
- +0.5%
- 4-year CAGR
- -12.6%
| Period | Period end | EPS (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 5.65 | +0.5% |
| FY2024 | 2024-12-31 | 5.62 | -3.3% |
| FY2023 | 2023-12-31 | 5.81 | +26.0% |
| FY2022 | 2022-12-31 | 4.61 | -52.4% |
| FY2021 | 2021-12-31 | 9.69 | — |
EPS (Diluted) vs competitors
How ALGN compares with its peers on the latest reported figures
- ALGN's LTM Jun 2026 EPS (Diluted) of $5.76 is the highest of the 3 companies compared; the peer median is $0.36.
- Its year-over-year change of -2.9% is the lowest of 3, against a peer median of +2192.0%.
- Over three fiscal years its annual growth of +7.0% compares with a peer median of -40.7%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | $5.76 | -2.9% | +7.0% | |
| LTM Oct 2026 | $3.87 | +4353.4% | -40.7% | |
| LTM Mar 2026 | -$3.15 | +30.6% | — | |
| Peer median (excluding ALGN) | $0.36 | +2192.0% | -40.7% | |
Competitors are the stored peer set for ALGN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.95B | 3.73B | 3.86B | 4B | 4.03B |
| Cost of Revenue | 1.02B | 1.1B | 1.16B | 1.2B | 1.28B |
| Gross Profit | 2.94B | 2.63B | 2.71B | 2.8B | 2.76B |
| Gross Margin | 74.3% | 70.5% | 70.1% | 70.0% | 68.3% |
| Research & Development | 250.32M | 305.26M | 346.83M | 364.2M | 369.91M |
| Selling, General & Admin | 1.71B | 1.67B | 1.7B | 1.76B | 1.76B |
| Operating Expenses | 1.96B | 1.99B | 2.06B | 2.19B | 2.14B |
| Depreciation & Amortization | 108.73M | 125.79M | 142.4M | 145.03M | 237.44M |
| EBITDA | 1.12B | 779.84M | 799.06M | 816.8M | 822.72M |
| EBITDA Margin | 28.4% | 20.9% | 20.7% | 20.4% | 20.4% |
| Operating Income | 976.4M | 642.6M | 643.34M | 607.63M | 616.22M |
| Operating Margin | 24.7% | 17.2% | 16.7% | 15.2% | 15.3% |
| Interest Income | 3.1M | 5.37M | 17.26M | 20.22M | 16.05M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 36.02M | (43.54M) | (2.13M) | 1.33M | (30.93M) |
| Income Before Tax | 1.01B | 599.06M | 641.2M | 608.96M | 585.29M |
| Pre-Tax Margin | 25.6% | 16.0% | 16.6% | 15.2% | 14.5% |
| Income Tax Expense | 240.4M | 237.48M | 196.15M | 187.6M | 174.94M |
| Net Income | 772.02M | 361.57M | 445.05M | 421.36M | 410.35M |
| Net Margin | 19.5% | 9.7% | 11.5% | 10.5% | 10.2% |
| EPS (Basic) | 9.78 | 4.62 | 5.82 | 5.63 | 5.66 |
| EPS (Diluted) | 9.69 | 4.61 | 5.81 | 5.62 | 5.65 |
| Weighted Avg Shares | 78.92M | 78.19M | 76.43M | 74.88M | 72.54M |
| Weighted Avg Shares (Diluted) | 79.67M | 78.42M | 76.57M | 74.99M | 72.59M |
Align Technology, Inc.
NASDAQ:ALGN
Intrinsic Alpha fair value
Locked
Current Price
$163.96
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.